Education
About Us
Working with TipRanks
Follow Us
Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826)
:6826
6826 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$21.70 - HK$42.95
Previous CloseN/A
Volume220.22K
Average Volume (3M)794.21K
Market Cap
HK$12.43B
Enterprise ValueHK$4.09B
Total Cash (Recent Filing)-¥1.46B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)12.6
Beta0.93
Next Earnings
Apr 25, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 20, 2024Dividend Yield3.2%
Share Statistics
EPS (TTM)0.37
Shares Outstanding39,141,840
10 Day Avg. Volume465,828
30 Day Avg. Volume794,208
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.42
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Shanghai Haohai Biological Technology Co., Ltd. Class H News
PremiumCompany Announcements
Shanghai Haohai Reports Q1 2025 Financial Results
PremiumCompany Announcements
Shanghai Haohai Biological Reports Modest Revenue Growth Amid Flat Profits
PremiumCompany Announcements
Shanghai Haohai Adjusts Share Incentive Scheme---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
3.60%
Mutual Funds
― Other Institutional Investors
92.98% Public Companies and
Individual Investors
6826 FAQ
What was Shanghai Haohai Biological Technology Co., Ltd. Class H’s price range in the past 12 months?
Shanghai Haohai Biological Technology Co., Ltd. Class H lowest stock price was HK$21.70 and its highest was HK$42.95 in the past 12 months.
What is Shanghai Haohai Biological Technology Co., Ltd. Class H’s market cap?
Shanghai Haohai Biological Technology Co., Ltd. Class H’s market cap is HK$12.43B.
When is Shanghai Haohai Biological Technology Co., Ltd. Class H’s upcoming earnings report date?
Shanghai Haohai Biological Technology Co., Ltd. Class H’s upcoming earnings report date is Apr 25, 2025 which is yesterday.
How were Shanghai Haohai Biological Technology Co., Ltd. Class H’s earnings last quarter?
Shanghai Haohai Biological Technology Co., Ltd. Class H released its earnings results on Apr 25, 2025. The company reported HK$0.414 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.414.
Is Shanghai Haohai Biological Technology Co., Ltd. Class H overvalued?
According to Wall Street analysts Shanghai Haohai Biological Technology Co., Ltd. Class H’s price is currently Overvalued.
Does Shanghai Haohai Biological Technology Co., Ltd. Class H pay dividends?
Shanghai Haohai Biological Technology Co., Ltd. Class H pays a Annually dividend of HK$0.436 which represents an annual dividend yield of 3.2%. See more information on Shanghai Haohai Biological Technology Co., Ltd. Class H dividends here
What is Shanghai Haohai Biological Technology Co., Ltd. Class H’s EPS estimate?
Shanghai Haohai Biological Technology Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Shanghai Haohai Biological Technology Co., Ltd. Class H have?
Shanghai Haohai Biological Technology Co., Ltd. Class H has 39,141,840 shares outstanding.
What happened to Shanghai Haohai Biological Technology Co., Ltd. Class H’s price movement after its last earnings report?
Shanghai Haohai Biological Technology Co., Ltd. Class H reported an EPS of HK$0.414 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.411%.
Which hedge fund is a major shareholder of Shanghai Haohai Biological Technology Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:6826
---
Shanghai Haohai Biological Technology Co., Ltd. Class H Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-6.61%
12-Months-Change
Fundamentals
Return on Equity
7.50%
Trailing 12-Months
Asset Growth
-3.13%
Trailing 12-Months
Company Description
Shanghai Haohai Biological Technology Co., Ltd. Class H
Shanghai Haohai Biological Technology Co., Ltd. Class H (6826) is a leading biotechnology company based in China, specializing in the research, development, manufacturing, and marketing of biomedical materials and products. The company operates primarily in the sectors of ophthalmology, medical aesthetics, orthopedics, and anti-adhesion materials. Haohai's core products include hyaluronic acid-based materials, intraocular lenses, and anti-adhesion products, which are utilized in various medical and cosmetic applications.
---
Technical Analysis
Ping An Insurance Company of China
―
Sino Biopharmaceutical
―
Huazhu Group Ltd
―
Livzon Pharmaceutical Group
―
CSPC Pharmaceutical Group
―
---